mantle cell lymphoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Phase 2 (1)

Interventional (2)

BeiGene (1)
Dana-Farber Cancer Institute (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadmantle cell lymphoma

I am/have/hadlymphoma

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadfollicular lymphoma

I am/have/hadchronic lymphocytic leukemia

I am/have/hadb-cell lymphoma

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadwaldenstrom's macroglobulinemia

I am/have/hadneutrophil count

I am/have/hadlarge b-cell lymphoma

I am/have/hadsystemic therapy

I am/have/hadct scan

I am/have/hadserum pregnancy test

I am/have/hadsolid tumors

I am/have/hadbone marrow biopsy

I am/have/hadrefractory follicular lymphoma

I am/have/hadigm level

I am/have/hadcancer, hepatocellular

I am/have/hadcarcinoma

added new label for I am/have/had

more

I am looking for

I am looking foribrutinib

I am looking forgrowth factor

I am looking forvenetoclax

I am looking fortislelizumab

I am looking formelanoma

I am looking forzanubrutinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Brief Title: Study of BGB-10188 as Monotherapy and in Combination With Zanubrutinib and Tislelizumab

The purpose of this study is to determine the maximum tolerated dose (MTD), recommended Phase 2 dose(RP2D),safety & tolerability of BGB-10188: as monotherapy in participants with mature B-cell malignancies; oin combination with zanubrutinib in participants with relapse/refractory follicular lymphoma (R/R FL), mantle cell lymphoma (MCL) or diffuse large B-cell lymphoma …

cancer, hepatocellular

systemic therapy

carcinoma

mantle cell lymphoma

solid tumour

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Hematology
Recruiting

Ibrutinib + Venetoclax in Untreated WM

This study evaluates the safety and efficacy of Ibrutinib combined with Venetoclax (IVEN) in the treatment of adults diagnosed with Waldenstrom's macroglobulinemia (WM) cancer with a specific MYD88 gene mutation. This research study involves an experimental drug combination of targeted therapies. The names of the study drugs involved in this …

bone marrow biopsy

measurable disease

plasmapheresis

neutrophil count

cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.